(Q43036592)

12 November 2017

title

Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders (English)

1 reference

12 November 2017

0 references

0 references

0 references

1 reference

1 reference

3

Goedert JJ

1 reference

12 November 2017

Messick K

1

1 reference

12 November 2017

Sanders JC

series ordinal

2

1 reference

12 November 2017

Eyster ME

series ordinal

4

1 reference

12 November 2017

publication date

1 November 2001

1 reference

12 November 2017

1 reference

12 November 2017

volume

7

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

568-574

1 reference

Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

The natural history of chronic hepatitis C in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Hepatitis C virus-infected, HCV-RNA-negative patients with bleeding disorders--relationship to age, HIV and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Full or partial seroreversion in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00559.X

10.1046/J.1365-2516.2001.00559.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference